Analgesics is expected to register moderate constant retail value sales growth over the forecast period, in line with population growth that will potentially increase the size of the consumer base. Furthermore, Algerians’ rising confidence in self-medicating is anticipated to continue driving constant retail value sales growth, especially given the declining quality of the public national health system that is resulting in long waiting times, weak patient management and thereby driving consumers to only use the system when in acute pain and need to obtain an analgesics prescription.
Consumers’ purchasing power is limited in 2022 and compounded by rising unemployment as a result of the economic downturn caused by the pandemic. This is likely to limit constant retail value sales growth of analgesics over the forecast period.
Adult diclofenac is expected to register relatively healthy constant retail value sales growth over the forecast period, although this growth will be from a low base. Adult diclofenac in addition to adult ketoprofen are anticipated to remain the most dynamic categories in analgesics.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Analgesics industry in Algeria with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Algeria, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See All of Our DefinitionsThis report originates from Passport, our Analgesics research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!